Fresenius fared even better, netting more than $1 billion in after-tax profit for 2015.
For the first quarter of this year, its revenue was up 6%, net income up 9%.
Da Vita has paid out nearly $1 billion since 2013 to settle three whistleblower suits.
Last year, it paid $495 million to settle a suit filed by two former employees accusing it of overbilling the Medicare and Medicaid programs.
Willem Johan Kolff’s invention of the dialysis machine was singularly heroic.
He cobbled together the first device from juice cans, sausage casings, and a washing machine — all the while running a hospital in wartime Europe and aiding the Dutch resistance.
Da Vita reported adjusted net income of 8 million for 2015, up more than 0 million from 2014.
Three-quarters of its cash flow stems from dialysis services.
The principles of dialysis have changed little since the first American underwent the procedure in 1948: toxins in a patient’s blood are filtered through a permeable membrane. Yet dialysis is now delivered — and leveraged — in a manner as systematic as the environment in which it was created was chaotic. Renal Data System, 468,000 patients underwent dialysis in 2013.
Dialysis is a big, profitable, and growing business in the United States. Patient empowerment may be a path to improving costs and outcomes alike. That’s a nearly 47-fold increase in 40 years, driven in part by the rise nationwide in diabetes, hypertension, and other chronic conditions.” Dialysis has always exacted a toll.